1. At a Glance – Blink and You’ll Miss the Drama
Dalmia Bharat is what happens when a 1939-born cement company decides to bulk up like a gym bro on infrastructure steroids. Current market cap sits around ₹41,752 Cr, stock price hovering near ₹2,232, and the market is valuing this concrete empire at ~35x P/E while ROE politely whispers 4–5%. Yes, that gap is as awkward as it sounds.
Q3 FY26 (Dec 2025) numbers show ₹3,506 Cr revenue, ₹602 Cr EBITDA, and ₹128 Cr PAT. EBITDA margins improved sequentially, volumes clocked 7.3 MnT, but EPS cooled to ₹6.5 — reminding investors that cement is cyclical, not crypto.
Three-month return? ~4.6%. One-year return? 26%. Dividend yield? A very sanskari 0.4%. Debt-to-equity at 0.40, so no heart attack yet. The company is expanding capacity aggressively while profitability is playing hard to get. Is this foresight or overconfidence? Hold that thought.
2. Introduction – Old Cement, New Headaches
Dalmia Bharat is India’s 4th largest cement manufacturer by installed capacity, which is corporate speak for “big enough to matter, not big enough to bully.” It plays across OPC, PPC, PSC, and PCC, with a heavy tilt towards blended cement — the kind regulators, ESG investors, and cost accountants all clap for.
But here’s the twist: while volumes are growing, realizations and EBITDA per ton have softened compared to FY23. Capacity utilization slipped to 63% in FY25 from 69% in FY23, which means the plants are there, but demand hasn’t RSVP’d enthusiastically enough.
Add to that:
- An ED provisional attachment of ₹793 Cr (legacy Bharathi Cement issue)
- West Bengal incentives worth ₹236 Cr getting revoked retrospectively
- A ₹4,000 Cr fund-raising approval
This isn’t a boring cement story. It’s a
